pipeline

Allakos, a biotechnology company focused on developing innovative therapies for allergic and inflammatory diseases, recently announced a significant workforce reduction...

Novartis, one of the world’s leading pharmaceutical companies, recently made a decision not to pursue a partnership with Cytokinetics, a...

A Comprehensive Overview of the Top 10 Biotech Funding Rounds in 2023 The biotech industry has been experiencing significant growth...

In today’s fast-paced and ever-evolving business landscape, staying ahead of the competition is crucial for success. With the rapid advancements...

Shipyard Faces Worker Shortage, Causing Delay in Frigate Program The shipbuilding industry plays a crucial role in the global economy,...

As a realtor, your success heavily relies on your ability to effectively network and close sales. In today’s digital age,...

Alnylam Pharmaceuticals, a leading biopharmaceutical company focused on RNA interference (RNAi) therapeutics, recently released its preliminary financial results for the...

Metagenomi and ArriVent Submit IPO Filings: Jan. 5 Quick Takes On January 5, 2022, two biotechnology companies, Metagenomi and ArriVent,...

On the eve of the J.P. Morgan Healthcare Conference, two major pharmaceutical companies, Sobi and Corteria, have announced significant management...

Allogene Therapeutics, a leading biotechnology company specializing in the development of innovative cell therapies for cancer treatment, has recently announced...

In the ever-evolving digital landscape, security incidents have become a major concern for individuals and organizations alike. As technology advances,...

Simulations Plus, a leading provider of simulation and modeling software for the pharmaceutical and biotechnology industries, recently announced its financial...

Asensus Surgical, Inc., a leading medical device company, is set to share its insights at the highly anticipated 42nd Annual...

A Comprehensive Look at the 257 Venture-Backed Startup Companies Set to Go Public in 2024: A Guide to the Promising...